Global Wound Biologics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 10-Nov-2022
No. of pages: 118
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Wound Biologics manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Wound Biologics market. Further, it explains the major drivers and regional dynamics of the global Wound Biologics market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Avita Medical

- ConvaTec

- Acelity

- Cytori Therapeutic

- MacroCure

- Nuo Therapeutics

- Molyncke Health Care

- Osiris Therapeutics

- Smith And Nephew

- Organogenesis

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Wound Biologics Segment by Type

- Biological Skin Substitutes

- Enzyme Preparation

- Growth Factor

Wound Biologics Segment by Application

- Hospital

- Drugstore

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Wound Biologics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Wound Biologics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Wound Biologics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Wound Biologics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Wound Biologics sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Wound Biologics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Wound Biologics sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Avita Medical, ConvaTec, Acelity, Cytori Therapeutic, MacroCure, Nuo Therapeutics, Molyncke Health Care, Osiris Therapeutics and Smith And Nephew, etc.

Global Wound Biologics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Wound Biologics Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Biological Skin Substitutes
1.2.3 Enzyme Preparation
1.2.4 Growth Factor
1.3 Market Segment by Application
1.3.1 Global Wound Biologics Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Drugstore
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Wound Biologics Market Size (2017-2028)
2.1.1 Global Wound Biologics Revenue (2017-2028)
2.1.2 Global Wound Biologics Sales (2017-2028)
2.2 Global Wound Biologics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Wound Biologics Sales by Regions (2017-2022)
2.2.2 Global Wound Biologics Revenue by Regions (2017-2022)
2.3 Global Wound Biologics Market Size Forecast by Region
2.3.1 Global Wound Biologics Sales Forecast by Region (2023-2028)
2.3.2 Global Wound Biologics Revenue Forecast by Region (2023-2028)
2.4 Global Top Wound Biologics Regions (Countries) Ranking by Market Size
2.5 Wound Biologics Market Dynamics
2.5.1 Wound Biologics Market Trends
2.5.2 Wound Biologics Market Drivers
2.5.3 Wound Biologics Market Challenges
2.5.4 Wound Biologics Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Wound Biologics Manufacturers by Sales (2017-2022)
3.1.1 Global Wound Biologics Sales by Manufacturers (2017-2022)
3.1.2 Global Wound Biologics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Wound Biologics Sales in 2021
3.2 Global Top Manufacturers Wound Biologics by Revenue
3.2.1 Global Wound Biologics Revenue by Manufacturers (2017-2022)
3.2.2 Top Wound Biologics Manufacturers Covered: Ranking by Revenue
3.2.3 Global Wound Biologics Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Wound Biologics Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Wound Biologics as of 2021)
3.4 Global Wound Biologics Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Wound Biologics Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Wound Biologics Market
3.7 Key Manufacturers Wound Biologics Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Wound Biologics Market Size by Type
4.1 Global Wound Biologics Historic Market Review by Type (2017-2022)
4.1.1 Global Wound Biologics Sales Market Share by Type (2017-2022)
4.1.2 Global Wound Biologics Revenue Market Share by Type (2017-2022)
4.1.3 Wound Biologics Price by Type (2017-2022)
4.2 Global Wound Biologics Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Wound Biologics Sales Forecast by Type (2023-2028)
4.2.2 Global Wound Biologics Revenue Forecast by Type (2023-2028)
4.2.3 Wound Biologics Price Forecast by Type (2023-2028)
5 Global Wound Biologics Market Size by Application
5.1 Global Wound Biologics Historic Market Review by Application (2017-2022)
5.1.1 Global Wound Biologics Sales Market Share by Application (2017-2022)
5.1.2 Global Wound Biologics Revenue Market Share by Application (2017-2022)
5.1.3 Wound Biologics Price by Application (2017-2022)
5.2 Global Wound Biologics Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Wound Biologics Sales Forecast by Application (2023-2028)
5.2.2 Global Wound Biologics Revenue Forecast by Application (2023-2028)
5.2.3 Wound Biologics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Wound Biologics Sales Breakdown by Company
6.1.1 North America Wound Biologics Sales by Company (2017-2022)
6.1.2 North America Wound Biologics Revenue by Company (2017-2022)
6.2 North America Wound Biologics Market Size by Type
6.2.1 North America Wound Biologics Sales by Type (2017-2028)
6.2.2 North America Wound Biologics Revenue by Type (2017-2028)
6.3 North America Wound Biologics Market Size by Application
6.3.1 North America Wound Biologics Sales by Application (2017-2028)
6.3.2 North America Wound Biologics Revenue by Application (2017-2028)
6.4 North America Wound Biologics Market Size by Country
6.4.1 North America Wound Biologics Sales by Country (2017-2028)
6.4.2 North America Wound Biologics Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Wound Biologics Sales Breakdown by Company
7.1.1 Europe Wound Biologics Sales by Company (2017-2022)
7.1.2 Europe Wound Biologics Revenue by Company (2017-2022)
7.2 Europe Wound Biologics Market Size by Type
7.2.1 Europe Wound Biologics Sales by Type (2017-2028)
7.2.2 Europe Wound Biologics Revenue by Type (2017-2028)
7.3 Europe Wound Biologics Market Size by Application
7.3.1 Europe Wound Biologics Sales by Application (2017-2028)
7.3.2 Europe Wound Biologics Revenue by Application (2017-2028)
7.4 Europe Wound Biologics Market Size by Country
7.4.1 Europe Wound Biologics Sales by Country (2017-2028)
7.4.2 Europe Wound Biologics Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Wound Biologics Sales Breakdown by Company
8.1.1 Asia Pacific Wound Biologics Sales by Company (2017-2022)
8.1.2 Asia Pacific Wound Biologics Revenue by Company (2017-2022)
8.2 Asia Pacific Wound Biologics Market Size by Type
8.2.1 Asia Pacific Wound Biologics Sales by Type (2017-2028)
8.2.2 Asia Pacific Wound Biologics Revenue by Type (2017-2028)
8.3 Asia Pacific Wound Biologics Market Size by Application
8.3.1 Asia Pacific Wound Biologics Sales by Application (2017-2028)
8.3.2 Asia Pacific Wound Biologics Revenue by Application (2017-2028)
8.4 Asia Pacific Wound Biologics Market Size by Region
8.4.1 Asia Pacific Wound Biologics Sales by Region
8.4.2 Asia Pacific Wound Biologics Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Wound Biologics Sales Breakdown by Company
9.1.1 Latin America Wound Biologics Sales by Company (2017-2022)
9.1.2 Latin America Wound Biologics Revenue by Company (2017-2022)
9.2 Latin America Wound Biologics Market Size by Type
9.2.1 Latin America Wound Biologics Sales by Type (2017-2028)
9.2.2 Latin America Wound Biologics Revenue by Type (2017-2028)
9.3 Latin America Wound Biologics Market Size by Application
9.3.1 Latin America Wound Biologics Sales by Application (2017-2028)
9.3.2 Latin America Wound Biologics Revenue by Application (2017-2028)
9.4 Latin America Wound Biologics Market Size by Country
9.4.1 Latin America Wound Biologics Sales by Country (2017-2028)
9.4.2 Latin America Wound Biologics Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Wound Biologics Sales Breakdown by Company
10.1.1 Middle East and Africa Wound Biologics Sales by Company (2017-2022)
10.1.2 Middle East and Africa Wound Biologics Revenue by Company (2017-2022)
10.2 Middle East and Africa Wound Biologics Market Size by Type
10.2.1 Middle East and Africa Wound Biologics Sales by Type (2017-2028)
10.2.2 Middle East and Africa Wound Biologics Revenue by Type (2017-2028)
10.3 Middle East and Africa Wound Biologics Market Size by Application
10.3.1 Middle East and Africa Wound Biologics Sales by Application (2017-2028)
10.3.2 Middle East and Africa Wound Biologics Revenue by Application (2017-2028)
10.4 Middle East and Africa Wound Biologics Market Size by Country
10.4.1 Middle East and Africa Wound Biologics Sales by Country (2017-2028)
10.4.2 Middle East and Africa Wound Biologics Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Avita Medical
11.1.1 Avita Medical Corporation Information
11.1.2 Avita Medical Overview
11.1.3 Avita Medical Wound Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Avita Medical Wound Biologics Products and Services
11.1.5 Avita Medical Wound Biologics SWOT Analysis
11.1.6 Avita Medical Recent Developments
11.2 ConvaTec
11.2.1 ConvaTec Corporation Information
11.2.2 ConvaTec Overview
11.2.3 ConvaTec Wound Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 ConvaTec Wound Biologics Products and Services
11.2.5 ConvaTec Wound Biologics SWOT Analysis
11.2.6 ConvaTec Recent Developments
11.3 Acelity
11.3.1 Acelity Corporation Information
11.3.2 Acelity Overview
11.3.3 Acelity Wound Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Acelity Wound Biologics Products and Services
11.3.5 Acelity Wound Biologics SWOT Analysis
11.3.6 Acelity Recent Developments
11.4 Cytori Therapeutic
11.4.1 Cytori Therapeutic Corporation Information
11.4.2 Cytori Therapeutic Overview
11.4.3 Cytori Therapeutic Wound Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Cytori Therapeutic Wound Biologics Products and Services
11.4.5 Cytori Therapeutic Wound Biologics SWOT Analysis
11.4.6 Cytori Therapeutic Recent Developments
11.5 MacroCure
11.5.1 MacroCure Corporation Information
11.5.2 MacroCure Overview
11.5.3 MacroCure Wound Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 MacroCure Wound Biologics Products and Services
11.5.5 MacroCure Wound Biologics SWOT Analysis
11.5.6 MacroCure Recent Developments
11.6 Nuo Therapeutics
11.6.1 Nuo Therapeutics Corporation Information
11.6.2 Nuo Therapeutics Overview
11.6.3 Nuo Therapeutics Wound Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Nuo Therapeutics Wound Biologics Products and Services
11.6.5 Nuo Therapeutics Wound Biologics SWOT Analysis
11.6.6 Nuo Therapeutics Recent Developments
11.7 Molyncke Health Care
11.7.1 Molyncke Health Care Corporation Information
11.7.2 Molyncke Health Care Overview
11.7.3 Molyncke Health Care Wound Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Molyncke Health Care Wound Biologics Products and Services
11.7.5 Molyncke Health Care Wound Biologics SWOT Analysis
11.7.6 Molyncke Health Care Recent Developments
11.8 Osiris Therapeutics
11.8.1 Osiris Therapeutics Corporation Information
11.8.2 Osiris Therapeutics Overview
11.8.3 Osiris Therapeutics Wound Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Osiris Therapeutics Wound Biologics Products and Services
11.8.5 Osiris Therapeutics Wound Biologics SWOT Analysis
11.8.6 Osiris Therapeutics Recent Developments
11.9 Smith And Nephew
11.9.1 Smith And Nephew Corporation Information
11.9.2 Smith And Nephew Overview
11.9.3 Smith And Nephew Wound Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Smith And Nephew Wound Biologics Products and Services
11.9.5 Smith And Nephew Wound Biologics SWOT Analysis
11.9.6 Smith And Nephew Recent Developments
11.10 Organogenesis
11.10.1 Organogenesis Corporation Information
11.10.2 Organogenesis Overview
11.10.3 Organogenesis Wound Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Organogenesis Wound Biologics Products and Services
11.10.5 Organogenesis Wound Biologics SWOT Analysis
11.10.6 Organogenesis Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Wound Biologics Value Chain Analysis
12.2 Wound Biologics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Wound Biologics Production Mode & Process
12.4 Wound Biologics Sales and Marketing
12.4.1 Wound Biologics Sales Channels
12.4.2 Wound Biologics Distributors
12.5 Wound Biologics Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Wound Biologics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Biological Skin Substitutes
Table 3. Major Manufacturers of Enzyme Preparation
Table 4. Major Manufacturers of Growth Factor
Table 5. Global Wound Biologics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Wound Biologics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Wound Biologics Sales by Region (2017-2022) & (K Units)
Table 8. Global Wound Biologics Sales Market Share by Region (2017-2022)
Table 9. Global Wound Biologics Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Wound Biologics Revenue Market Share by Region (2017-2022)
Table 11. Global Wound Biologics Sales Forecast by Region (2023-2028) & (K Units)
Table 12. Global Wound Biologics Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Wound Biologics Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Wound Biologics Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Wound Biologics Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Wound Biologics Market Trends
Table 17. Wound Biologics Market Drivers
Table 18. Wound Biologics Market Challenges
Table 19. Wound Biologics Market Restraints
Table 20. Global Wound Biologics Sales by Manufacturers (2017-2022) & (K Units)
Table 21. Global Wound Biologics Sales Share by Manufacturers (2017-2022)
Table 22. Global Wound Biologics Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Wound Biologics Manufacturers by Revenue (US$ Million) in 2021
Table 24. Wound Biologics Revenue Share by Manufacturers (2017-2022)
Table 25. Global Wound Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Wound Biologics as of 2021)
Table 27. Key Manufacturers Wound Biologics Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 28. Key Manufacturers Wound Biologics Plants/Factories Distribution
Table 29. Key Manufacturers Wound Biologics Area Served
Table 30. Date of Key Manufacturers Enter into Wound Biologics Market
Table 31. Key Manufacturers Wound Biologics Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Wound Biologics Sales (K Units) by Type (2017-2022)
Table 34. Global Wound Biologics Sales Share by Type (2017-2022)
Table 35. Global Wound Biologics Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Wound Biologics Price (K Units) by Type (2017-2022)
Table 37. Global Wound Biologics Sales (K Units) by Type (2023-2028)
Table 38. Global Wound Biologics Sales Share by Type (2023-2028)
Table 39. Global Wound Biologics Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Wound Biologics Revenue Share by Type (2023-2028)
Table 41. Global Wound Biologics Price (K Units) by Type (2023-2028)
Table 42. Global Wound Biologics Sales (K Units) by Application (2017-2022)
Table 43. Global Wound Biologics Sales Share by Application (2017-2022)
Table 44. Global Wound Biologics Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Wound Biologics Price (K Units) by Application (2017-2022)
Table 46. Global Wound Biologics Sales (K Units) by Application (2023-2028)
Table 47. Global Wound Biologics Sales Share by Application (2023-2028)
Table 48. Global Wound Biologics Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Wound Biologics Revenue Share by Application (2023-2028)
Table 50. Global Wound Biologics Price (K Units) by Application (2023-2028)
Table 51. North America Wound Biologics Sales by Company (2017-2022) & (K Units)
Table 52. North America Wound Biologics Sales Market Share by Company (2017-2022)
Table 53. North America Wound Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Wound Biologics Revenue Market Share by Company (2017-2022)
Table 55. North America Wound Biologics Sales by Type (2017-2022) & (K Units)
Table 56. North America Wound Biologics Sales by Type (2023-2028) & (K Units)
Table 57. North America Wound Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Wound Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Wound Biologics Sales by Application (2017-2022) & (K Units)
Table 60. North America Wound Biologics Sales by Application (2023-2028) & (K Units)
Table 61. North America Wound Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Wound Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Wound Biologics Sales by Country (2017-2022) & (K Units)
Table 64. North America Wound Biologics Sales by Country (2023-2028) & (K Units)
Table 65. North America Wound Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Wound Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Wound Biologics Sales by Company (2017-2022) & (K Units)
Table 68. Europe Wound Biologics Sales Market Share by Company (2017-2022)
Table 69. Europe Wound Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Wound Biologics Revenue Market Share by Company (2017-2022)
Table 71. Europe Wound Biologics Sales by Type (2017-2022) & (K Units)
Table 72. Europe Wound Biologics Sales by Type (2023-2028) & (K Units)
Table 73. Europe Wound Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Wound Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Wound Biologics Sales by Application (2017-2022) & (K Units)
Table 76. Europe Wound Biologics Sales by Application (2023-2028) & (K Units)
Table 77. Europe Wound Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Wound Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Wound Biologics Sales by Country (2017-2022) & (K Units)
Table 80. Europe Wound Biologics Sales by Country (2023-2028) & (K Units)
Table 81. Europe Wound Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Wound Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Wound Biologics Sales by Company (2017-2022) & (K Units)
Table 84. Asia Pacific Wound Biologics Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Wound Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Wound Biologics Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Wound Biologics Sales by Type (2017-2022) & (K Units)
Table 88. Asia Pacific Wound Biologics Sales by Type (2023-2028) & (K Units)
Table 89. Asia Pacific Wound Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Wound Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Wound Biologics Sales by Application (2017-2022) & (K Units)
Table 92. Asia Pacific Wound Biologics Sales by Application (2023-2028) & (K Units)
Table 93. Asia Pacific Wound Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Wound Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Wound Biologics Sales by Region (2017-2022) & (K Units)
Table 96. Asia Pacific Wound Biologics Sales by Region (2023-2028) & (K Units)
Table 97. Asia Pacific Wound Biologics Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Wound Biologics Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Wound Biologics Sales by Company (2017-2022) & (K Units)
Table 100. Latin America Wound Biologics Sales Market Share by Company (2017-2022)
Table 101. Latin America Wound Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Wound Biologics Revenue Market Share by Company (2017-2022)
Table 103. Latin America Wound Biologics Sales by Type (2017-2022) & (K Units)
Table 104. Latin America Wound Biologics Sales by Type (2023-2028) & (K Units)
Table 105. Latin America Wound Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Wound Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Wound Biologics Sales by Application (2017-2022) & (K Units)
Table 108. Latin America Wound Biologics Sales by Application (2023-2028) & (K Units)
Table 109. Latin America Wound Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Wound Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Wound Biologics Sales by Country (2017-2022) & (K Units)
Table 112. Latin America Wound Biologics Sales by Country (2023-2028) & (K Units)
Table 113. Latin America Wound Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Wound Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Wound Biologics Sales by Company (2017-2022) & (K Units)
Table 116. Middle East and Africa Wound Biologics Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Wound Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Wound Biologics Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Wound Biologics Sales by Type (2017-2022) & (K Units)
Table 120. Middle East and Africa Wound Biologics Sales by Type (2023-2028) & (K Units)
Table 121. Middle East and Africa Wound Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Wound Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Wound Biologics Sales by Application (2017-2022) & (K Units)
Table 124. Middle East and Africa Wound Biologics Sales by Application (2023-2028) & (K Units)
Table 125. Middle East and Africa Wound Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Wound Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Wound Biologics Sales by Country (2017-2022) & (K Units)
Table 128. Middle East and Africa Wound Biologics Sales by Country (2023-2028) & (K Units)
Table 129. Middle East and Africa Wound Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Wound Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 131. Avita Medical Corporation Information
Table 132. Avita Medical Description and Overview
Table 133. Avita Medical Wound Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 134. Avita Medical Wound Biologics Product and Services
Table 135. Avita Medical Wound Biologics SWOT Analysis
Table 136. Avita Medical Recent Developments
Table 137. ConvaTec Corporation Information
Table 138. ConvaTec Description and Overview
Table 139. ConvaTec Wound Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 140. ConvaTec Wound Biologics Product and Services
Table 141. ConvaTec Wound Biologics SWOT Analysis
Table 142. ConvaTec Recent Developments
Table 143. Acelity Corporation Information
Table 144. Acelity Description and Overview
Table 145. Acelity Wound Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 146. Acelity Wound Biologics Product and Services
Table 147. Acelity Wound Biologics SWOT Analysis
Table 148. Acelity Recent Developments
Table 149. Cytori Therapeutic Corporation Information
Table 150. Cytori Therapeutic Description and Overview
Table 151. Cytori Therapeutic Wound Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 152. Cytori Therapeutic Wound Biologics Product and Services
Table 153. Cytori Therapeutic Wound Biologics SWOT Analysis
Table 154. Cytori Therapeutic Recent Developments
Table 155. MacroCure Corporation Information
Table 156. MacroCure Description and Overview
Table 157. MacroCure Wound Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 158. MacroCure Wound Biologics Product and Services
Table 159. MacroCure Wound Biologics SWOT Analysis
Table 160. MacroCure Recent Developments
Table 161. Nuo Therapeutics Corporation Information
Table 162. Nuo Therapeutics Description and Overview
Table 163. Nuo Therapeutics Wound Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 164. Nuo Therapeutics Wound Biologics Product and Services
Table 165. Nuo Therapeutics Wound Biologics SWOT Analysis
Table 166. Nuo Therapeutics Recent Developments
Table 167. Molyncke Health Care Corporation Information
Table 168. Molyncke Health Care Description and Overview
Table 169. Molyncke Health Care Wound Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 170. Molyncke Health Care Wound Biologics Product and Services
Table 171. Molyncke Health Care Wound Biologics SWOT Analysis
Table 172. Molyncke Health Care Recent Developments
Table 173. Osiris Therapeutics Corporation Information
Table 174. Osiris Therapeutics Description and Overview
Table 175. Osiris Therapeutics Wound Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 176. Osiris Therapeutics Wound Biologics Product and Services
Table 177. Osiris Therapeutics Wound Biologics SWOT Analysis
Table 178. Osiris Therapeutics Recent Developments
Table 179. Smith And Nephew Corporation Information
Table 180. Smith And Nephew Description and Overview
Table 181. Smith And Nephew Wound Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 182. Smith And Nephew Wound Biologics Product and Services
Table 183. Smith And Nephew Wound Biologics SWOT Analysis
Table 184. Smith And Nephew Recent Developments
Table 185. Organogenesis Corporation Information
Table 186. Organogenesis Description and Overview
Table 187. Organogenesis Wound Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 188. Organogenesis Wound Biologics Product and Services
Table 189. Organogenesis Wound Biologics SWOT Analysis
Table 190. Organogenesis Recent Developments
Table 191. Key Raw Materials Lists
Table 192. Raw Materials Key Suppliers Lists
Table 193. Wound Biologics Distributors List
Table 194. Wound Biologics Customers List
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Wound Biologics Product Picture
Figure 2. Global Wound Biologics Sales Market Share by Type in 2021 & 2028
Figure 3. Biological Skin Substitutes Product Picture
Figure 4. Enzyme Preparation Product Picture
Figure 5. Growth Factor Product Picture
Figure 6. Global Wound Biologics Sales Market Share by Application in 2021 & 2028
Figure 7. Hospital Use Case
Figure 8. Drugstore Use Case
Figure 9. Others Use Case
Figure 10. Wound Biologics Report Years Considered
Figure 11. Global Wound Biologics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Wound Biologics Market Size 2017-2028 (US$ Million)
Figure 13. Global Wound Biologics Sales (2017-2022) & (K Units)
Figure 14. Global Wound Biologics Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Wound Biologics Sales Market Share by Region (2017-2022)
Figure 16. Global Wound Biologics Sales Market Share by Region in 2021
Figure 17. Global Wound Biologics Revenue Market Share by Region in 2017 VS 2021
Figure 18. Global Wound Biologics Sales Share by Manufacturers in 2021
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Wound Biologics Sales in 2021
Figure 20. Wound Biologics Revenue Share by Manufacturers in 2021
Figure 21. Wound Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Wound Biologics Revenue Share by Type (2017-2022)
Figure 23. Global Wound Biologics Revenue Growth Rate by Type in 2017 & 2021
Figure 24. Global Wound Biologics Revenue Share by Application (2017-2022)
Figure 25. Global Wound Biologics Revenue Growth Rate by Application in 2017 & 2021
Figure 26. North America Wound Biologics Sales Market Share by Type (2017-2028)
Figure 27. North America Wound Biologics Revenue Market Share by Type (2017-2028)
Figure 28. North America Wound Biologics Sales Market Share by Application (2017-2028)
Figure 29. North America Wound Biologics Revenue Market Share by Application (2017-2028)
Figure 30. North America Wound Biologics Sales Share by Country (2017-2028)
Figure 31. North America Wound Biologics Revenue Share by Country (2017-2028)
Figure 32. U.S. Wound Biologics Revenue (2017-2028) & (US$ Million)
Figure 33. Canada Wound Biologics Revenue (2017-2028) & (US$ Million)
Figure 34. Europe Wound Biologics Sales Market Share by Type (2017-2028)
Figure 35. Europe Wound Biologics Revenue Market Share by Type (2017-2028)
Figure 36. Europe Wound Biologics Sales Market Share by Application (2017-2028)
Figure 37. Europe Wound Biologics Revenue Market Share by Application (2017-2028)
Figure 38. Europe Wound Biologics Sales Share by Country (2017-2028)
Figure 39. Europe Wound Biologics Revenue Share by Country (2017-2028)
  • Global Negative Pressure Wound Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Negative Pressure Wound Therapy market size was valued at US$ 1599.4 million in 2023. With growing demand in downstream market, the Negative Pressure Wound Therapy is forecast to a readjusted size of US$ 2440.8 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Negative Pressure Wound Therapy market. Negative Pressure Wound Therapy are expected to show s......
  • Global Wound Care Biologics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113
    According to our LPI (LP Information) latest study, the global Wound Care Biologics market size was valued at US$ 3854.3 million in 2023. With growing demand in downstream market, the Wound Care Biologics is forecast to a readjusted size of US$ 8052.7 million by 2030 with a CAGR of 11.1% during review period. The research report highlights the growth potential of the global Wound Care Biologics market. Wound Care Biologics are expected to show stable growth in the future market. However,......
  • Global Bioactive Wound Care Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 105
    Report Overview: Conventional wound healing turns out unproductive in healing acute wounds such as deep cuts, burn injuries, and chronic ulcers. Introduction of bioactive wound care products has efficiently provided solution to treat such critical wounds and injuries. Bioactive wound dressings control infection and hasten healing process, reduce the risk of leakage, alleviate pain and discomfort. The Global Bioactive Wound Care Market Size was estimated at USD 9362.40 million in 2022......
  • Global Wound Debridement Professional Survey Report 2023, Forecast to 2028
    Published: 08-Dec-2023        Price: US 3280 Onwards        Pages: 104
    Debridement is the removal of dead (necrotic) or infected skin tissue to help a wound heal. It's also done to remove foreign material from tissue.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adva......
  • Global Wound Debridement Market Research Report 2023, Forecast to 2028
    Published: 08-Dec-2023        Price: US 2680 Onwards        Pages: 162
    Debridement is the removal of dead (necrotic) or infected skin tissue to help a wound heal. It's also done to remove foreign material from tissue.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adva......
  • Global Negative Pressure Wound Therapy Market Insights, Forecast to 2029
    Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 97
    The Negative Pressure Wound Therapy Dressing Kits industry can be broken down into several segments, Black Foam, White Foam, etc. Across the world, the major players cover Smith & Nephew, 3M KCI, etc. This report mainly studies negative pressure wound therapy dressing kits market. The global Negative Pressure Wound Therapy market is projected to grow from US$ 1741.4 million in 2023 to US$ 2470.3 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast per......
  • Global Wound Care Market (by Product Type, Application, Wound Type, Region and Company), Size, Share, Acquisitions, Recent Developments - Forecast to 2030
    Published: 10-Jul-2023        Price: US 2190 Onwards        Pages: 216
    The global wound care market is predicted to surpass US$ 30.1 Billion by 2030. The market for wound care products is increasing owing to the growing number of surgical cases, rising geriatric population, and surge in the prevalence of chronic diseases across the globe. The increasing incidence of diabetes due to the widespread adoption of a sedentary lifestyle is one of the leading factors contributing significantly to the market growth. According to California Podiatric Medical Association (......
  • Global Negative Pressure Wound Therapy (NPWT) Market Insights, Forecast to 2029
    Published: 28-Jun-2023        Price: US 4900 Onwards        Pages: 95
    The Negative Pressure Wound Therapy Dressing Kits industry can be broken down into several segments, Black Foam, White Foam, etc. Across the world, the major players cover Smith & Nephew, 3M KCI, etc. This report mainly studies negative pressure wound therapy dressing kits market. The global Negative Pressure Wound Therapy (NPWT) market is projected to grow from US$ 1698.9 million in 2023 to US$ 2076.3 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.4% during ......
  • Global Wound Biologics Market Insights, Forecast to 2029
    Published: 16-Jun-2023        Price: US 4900 Onwards        Pages: 109
    Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing. Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venou......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs